Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$9K Sell
32
-68
-68% -$19.9K ﹤0.01% 1297
2023
Q4
$28K Sell
100
-90
-47% -$24.5K ﹤0.01% 1763
2023
Q3
$51K Sell
190
-210
-53% -$52.4K 0.01% 1491
2023
Q2
$88K Buy
+400
New +$92.8K 0.01% 983
2023
Q1
Sell
-11,733
Closed -$2.88M 3718
2022
Q4
$3.08M Buy
11,733
+6,375
+119% +$1.71M 0.26% 78
2022
Q3
$1.21M Sell
5,358
-7,669
-59% -$1.86M 0.08% 250
2022
Q2
$3.17M Buy
+13,027
New +$3.19M 0.22% 92
2021
Q1
Sell
-4,025
Closed -$925K 5560
2020
Q4
$925K Buy
4,025
+4,000
+16,000% +$922K 0.04% 417
2020
Q3
$6K Sell
25
-37
-60% -$9.17K ﹤0.01% 3312
2020
Q2
$14K Sell
62
-123
-66% -$28.1K ﹤0.01% 2612
2020
Q1
$37K Hold
185
﹤0.01% 1906
2019
Q4
$44K Sell
185
-2,227
-92% -$491K ﹤0.01% 1702
2019
Q3
$466K Buy
+2,412
New +$463K 0.04% 380
2019
Q2
Sell
-954
Closed -$171K 4160
2019
Q1
$181K Sell
954
-3,631
-79% -$693K 0.02% 691
2018
Q4
$892K Buy
4,585
+500
+12% +$97.5K 0.08% 206
2018
Q3
$846K Buy
4,085
+2,300
+129% +$453K 0.06% 313
2018
Q2
$329K Sell
1,785
-13,470
-88% -$2.38M 0.03% 577
2018
Q1
$2.6M Buy
15,255
+859
+6% +$158K 0.22% 79
2017
Q4
$2.5M Sell
14,396
-6,021
-29% -$1.07M 0.1% 133
2017
Q3
$3.81M Buy
20,417
+16,391
+407% +$2.9M 0.14% 106
2017
Q2
$693K Sell
4,026
-46,730
-92% -$7.6M 0.03% 535
2017
Q1
$8.33M Buy
50,756
+38,288
+307% +$6.36M 0.35% 51
2016
Q4
$1.82M Sell
12,468
-4,831
-28% -$727K 0.07% 226
2016
Q3
$2.88M Sell
17,299
-4,587
-21% -$776K 0.13% 119
2016
Q2
$3.33M Buy
21,886
+19,849
+974% +$3.09M 0.17% 86
2016
Q1
$305K Buy
2,037
+1,910
+1,504% +$284K 0.02% 754
2015
Q4
$20K Buy
+127
New +$20K ﹤0.01% 3405

Other funds holding AMGN

Cutler Group's AMGN Position: Q1 2024 in Review

Cutler Group reduced its Amgen (AMGN) stake by 68% in Q1 2024, selling an estimated $19.9K and leaving 32 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #1297.

Cutler Group first reported a position in AMGN in Q4 2015 and has held it in 27 quarters since. The position peaked at $8.33M in Q1 2017. 2,715 funds tracked by Wall St. Rank hold AMGN as of Q1 2024.

  • Cutler Group held 32 shares of Amgen worth $9K as of Q1 2024.
  • Cutler Group sold 68 Amgen shares in Q1 2024, an estimated $19.9K.
  • Amgen made up ﹤0.01% of Cutler Group's portfolio in Q1 2024, its #1297 holding.
  • Cutler Group first reported a position in Amgen in Q4 2015 and has held it in 27 quarters since.
  • Cutler Group's Amgen position peaked at $8.33M in Q1 2017.
  • 2,715 funds tracked by Wall St. Rank held Amgen as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.